963 / 1609
Dosimetry
•
Dose may be defined at HR-CTV or IR-CTV
•
Conventional loading patterns for tandem and vaginal
source are the basis for initial dwell times
•
Interstitial applicators should account for 10-15% of
the total
•
OAR tolerances should be defined and
respected…..but clinical compromise often required